Safety and Effectiveness of Levosimendan in Patients with Predominant Right Heart Failure
Safety and Effectiveness of Levosimendan in Patients with Predominant Right Heart Failure is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Safety and Effectiveness of Levosimendan in Patients with Predominant Right Heart Failure have?
Safety and Effectiveness of Levosimendan in Patients with Predominant Right Heart Failure has 57 citations in the OpenAlex counts ScholarIQ stores.
When was Safety and Effectiveness of Levosimendan in Patients with Predominant Right Heart Failure published?
Safety and Effectiveness of Levosimendan in Patients with Predominant Right Heart Failure has 2008 year in the ScholarIQ index.
What is the open-access status of Safety and Effectiveness of Levosimendan in Patients with Predominant Right Heart Failure?
Safety and Effectiveness of Levosimendan in Patients with Predominant Right Heart Failure has closed oa status in the ScholarIQ index.
What is the DOI of Safety and Effectiveness of Levosimendan in Patients with Predominant Right Heart Failure?
The DOI for Safety and Effectiveness of Levosimendan in Patients with Predominant Right Heart Failure is on the source record.
What is the PMID of Safety and Effectiveness of Levosimendan in Patients with Predominant Right Heart Failure?
The PMID for Safety and Effectiveness of Levosimendan in Patients with Predominant Right Heart Failure is on the source record.
What is the OpenAlex record for Safety and Effectiveness of Levosimendan in Patients with Predominant Right Heart Failure?
The OpenAlex for Safety and Effectiveness of Levosimendan in Patients with Predominant Right Heart Failure is on the source record.